PubRank
Search
About
E V Vlasova
Author PubWeight™ 3.26
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Association of prognosis in surgically treated lung cancer patients with cytometric, histometric and ligand histochemical properties: with an emphasis on structural entropy.
Anal Quant Cytol Histol
1998
0.86
2
[Isolation and characteristics of purified lecitsinase from Cl. perfringens].
Biokhimiia
1966
0.81
3
[The study of the formation of lecithinase by Clostridium perfringens type A].
Biokhimiia
1968
0.80
4
Summary report on the ISOBM TD-6 workshop: analysis of 20 monoclonal antibodies against Sialyl Lewisa and related antigens. Montreux, Switzerland, September 19-24, 1997.
Tumour Biol
1998
0.79
5
[Immunologic characteristics of the purified and concentrated anatoxins of Cl. histolyticum].
Zh Mikrobiol Epidemiol Immunobiol
1968
0.75
6
[Determination of the activity of antitoxic sera against Cl. oedematiens in tissue culture].
Zh Mikrobiol Epidemiol Immunobiol
1967
0.75
7
[Properties of C1. perfringens toxoids obtained from purified toxins].
Zh Mikrobiol Epidemiol Immunobiol
1977
0.75
8
[Sensitivity of mice, immunized with Cl. oedematiens and Cl. sordellii, to homologous toxins with different routes of administration].
Biull Eksp Biol Med
1972
0.75
9
[Immunization against gas gangrene and tetanus with sexta-anatoxin (in experiments with animals)].
Zh Mikrobiol Epidemiol Immunobiol
1969
0.75
10
On the in vitro neutralization test of Clostridium perfringens type A toxin.
J Hyg Epidemiol Microbiol Immunol
1988
0.75
11
[Biological properties of salmonellae and local immunity in Salmonella infection].
Zh Mikrobiol Epidemiol Immunobiol
2006
0.75
12
[Use of the passive hemagglutination test for the purpose of determining antibody levels following animal immunization with Cl. perfringens toxoid].
Zh Mikrobiol Epidemiol Immunobiol
1977
0.75
13
[Selectin receptors. 5. Monoclonal antibodies to the synthetic antigens SiaLe(a) and SiaLe(x)].
Bioorg Khim
1996
0.75
14
[Sensitivity of mice to toxins of the causative agents of gas gangrene administered by different methods].
Zh Mikrobiol Epidemiol Immunobiol
1971
0.75
15
[Albino mice as a model for determining the immunogenic properties of Cl. sordelli toxoids].
Zh Mikrobiol Epidemiol Immunobiol
1965
0.75
16
[Antigenic and immunogenic properties of the purified collagenase of Cl. histolyticum].
Zh Mikrobiol Epidemiol Immunobiol
1968
0.75
17
[Obtaining highly purified preparations of Cl. histolyticum lethal factor].
Vopr Med Khim
1969
0.75
18
[Isolation and properties of lecithinase from Clostridium perfringens].
Biokhimiia
1968
0.75
19
[Determination of lecithinase activity in Clostridium perfringens by its action upon liver lysosomes in rats].
Vopr Med Khim
1970
0.75
20
[Determination of the activity of the toxins of Cl. histolyticum in tissue culture].
Zh Mikrobiol Epidemiol Immunobiol
1967
0.75
21
[Dose-effect relationship in immunization of mice with purified edematiense anatoxin].
Biull Eksp Biol Med
1968
0.75
22
[Characteristics of the immunologic response of animals to Clostridium perfringens anatoxin].
Zh Mikrobiol Epidemiol Immunobiol
1977
0.75
23
[Extraction of highly purified anatoxins].
Zh Mikrobiol Epidemiol Immunobiol
1966
0.75
24
[Morphologic and histochemical changes in the bodies of guinea pigs caused by the toxin of Cl. sordelli].
Zh Mikrobiol Epidemiol Immunobiol
1967
0.75
25
[The relationship between survival time of mice and the dose of intravenously administered toxin of the agent of gas gangrene].
Zh Mikrobiol Epidemiol Immunobiol
1973
0.75
26
Comparative study on the immunogenic properties of Clostridium perfringens type A toxoid.
J Hyg Epidemiol Microbiol Immunol
1986
0.75
27
[Pathomorphological and histochemical changes caused by Cl. histolyticum collagenase in guinea pigs].
Zh Mikrobiol Epidemiol Immunobiol
1972
0.75
28
[Comparative evaluation of the methods of determining perfringens A antitoxin].
Biull Eksp Biol Med
1983
0.75
29
[Morphologic and some histochemical changes in the organism of immune guinea pigs during intramuscular injection of Cl. sordelli toxin].
Zh Mikrobiol Epidemiol Immunobiol
1971
0.75
30
[Use of tissue culture for detection of specific toxins of the causative agents of gas gangrene].
Zh Mikrobiol Epidemiol Immunobiol
1971
0.75
31
[Factors modulating production of antibodies against Clostridium perfringens in mammals].
Biull Eksp Biol Med
1981
0.75
32
[Study of fluorescence from isolated yeast plasma membranes in visible range of the spectrum].
Biofizika
1998
0.75
33
[Immune response of mice of different inbred lines to Clostridium oedematiens anatoxin].
Biull Eksp Biol Med
1977
0.75
34
[Sensitivity of mice to Cl. oedematiens toxin with different eans of administeringit].
Biull Eksp Biol Med
1969
0.75
35
The detection of the factor lowering the immunogenicity of toxoid of Clostridium perfringens type A.
Arch Roum Pathol Exp Microbiol
1982
0.75
36
[Palivizumab: four seasons in Russia].
Vestn Ross Akad Med Nauk
2014
0.75
37
[Immunogenic properties of Cl. perfringens anatoxins obtained from purified toxins].
Zh Mikrobiol Epidemiol Immunobiol
1975
0.75
38
[Morphological and some histochemical changes caused by Cl. sordellii and oedematiens toxins in cultures of fibroblasts, kidney epithelium and macrophages].
Zh Mikrobiol Epidemiol Immunobiol
1971
0.75
39
[The role of Cl. perfringens lecithinase in the effect of the toxin on tissue cultures].
Zh Mikrobiol Epidemiol Immunobiol
1966
0.75
40
Monoclonal antibody LU-BCRU-G7 against a breast tumour-associated glycoprotein recognizes the disaccharide Gal beta 1-3GlcNAc.
Glycobiology
1995
0.75
41
Purification of monoclonal antibodies to Le(y) and Le(d) carbohydrate antigens by ion-exchange and thiophilic-adsorption chromatography.
Bioseparation
1995
0.75
42
[A method of determining anticollagenase in antihistolyticus sera].
Zh Mikrobiol Epidemiol Immunobiol
1967
0.75